AV
Agilent Ventures
Corporate VCModeratePut simply, Agilent Ventures invests in private early-stage high-technology companies. The organization focuses on investments in life
8
Investments
1
Exits
—
AUM
12.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Agilent Ventures.
Investment Thesis & Strategy
Agilent Ventures, as a corporate venture capital arm, invests in early-stage, high-technology companies across the life sciences sector. They seek to partner with companies that align with Agilent's strategic interests.
Investment Activity
Deals per year over the last 9 years
1
20150
20160
20172
20180
20191
20202
20211
20222
2023Portfolio Companies
Selected investments from their portfolio of 8 companies
C
Cellino
Biotech · Series A, 2023
E
Enveda Biosciences
Biotech · Series B, 2023
U
Ultima Genomics
Biotech · Series B, 2022
S
Standard BioTools
Biotech · Growth, 2021
E
Element Biosciences
Biotech · Series C+, 2021
S
Singular Genomics
Biotech · Series B, 2020
B
Berkeley Lights
Biotech · Seed, 2018
S
Seer
Biotech · Series B, 2018
1
10x Genomics
Biotech · Series C+, 2015
Frequently Asked Questions
Agilent Ventures focuses on Series A, Series B stage investments.
Related Investors
Dell Technologies Capital
Palo Alto, United States · 189 deals
BP Ventures
Palo Alto, United States · 48 deals
Takeda Ventures
Palo Alto, United States · 48 deals
Rogers Venture Partners
Palo Alto, United States · 25 deals
Yamaha Motor Ventures & Laboratory Silicon Valley
Palo Alto, United States · 13 deals
HP Tech Ventures
Palo Alto, United States · 10 deals